Xenetic Biosciences Inc.
XBIO | NASDAQ
$2.51
-$0.48 (-16.05%)
Sep 22, 2026, 11:54 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.98M | 2.5M | 2.54M | 1.71M | 1.16M | 436.94K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 2.98M | 2.5M | 2.54M | 1.71M | 1.16M | 436.94K |
Operating Income | -2.83M | -4.2M | -4.52M | -6.72M | -5.75M | -13.94M |
Interest Income | 148K | 249.86K | 355.76K | 167.15K | 100.47K | 126.17K |
Pretax Income | -2.68M | -3.96M | -4.13M | -6.55M | -5.65M | -13.81M |
Net Income | -2.68M | -3.96M | -4.13M | -6.55M | -5.65M | -10.89M |
Selling & General & Admin | 2.75M | 3.42M | 3.56M | 3.65M | 3.74M | 3.4M |
Research & Development | 3.07M | 3.29M | 3.49M | 4.77M | 3.16M | 1.73M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 9.24M |
Operating Expenses | 5.81M | 6.7M | 7.06M | 8.42M | 6.91M | 14.37M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 5.81M | 6.7M | 7.06M | 8.42M | 6.91M | 14.37M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -2.92M |
Shares Outstanding (Basic) | 1.7M | 1.54M | 1.53M | 1.42M | 1.03M | 639.24K |
Shares Outstanding (Diluted) | 1.7M | 1.54M | 1.53M | 1.42M | 1.03M | 639.24K |
EPS (Basic) | -1.58 | -2.57 | -2.71 | -4.49 | -5.39 | -17.04 |
EPS (Diluted) | -1.58 | -2.57 | -2.71 | -4.49 | -5.39 | -17.04 |
EBITDA | -2.68M | -3.81M | -4.13M | -6.53M | -5.61M | -4.67M |
EBIT | -2.68M | -3.96M | -4.13M | -6.55M | -5.65M | -4.69M |
Depreciation & Amortization | n/a | 153.34K | n/a | 27.04K | 35.48K | 28.84K |
Add to Watchlist
Select watchlists to add or remove XBIO